Welcome : Guest

Medgenics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Medgenics, Inc., which is principally involved in Developing Medicines for Treating Clinical Stage Rare and Orphan Diseases. Illustrated with 13 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-64866
Price: $650
Company Type: Public
Pages: 16
Date: April 2016
Market Data Tables: 13

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......3
Table 1: Biopharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......3
Biologics......4
Table 2: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......4
Table 3: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......5
Table 4: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......6
Table 5: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......7
Table 6: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......8
Biosimilars......9
Table 7: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......9
Orphan Drugs......10
Table 8: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......10
Autologous Stem Cells......11
Table 9: Autologous Stem Cell Market by Disease Worldwide (2014) - Percentage Share Breakdown by Value for Infection, New Malignancy, Organ Failure, Primary Disease and Others......11
Biopharmaceuticals......12
Table 10: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......12
Biosimilars......13
Table 11: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015) - Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......13
Orphan Drugs......14
Table 12: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......14
Table 13: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......15